Risperdal is known as an atypical antipsychotic drug. It is approved to treat schizophrenia in adults and adolescents, bipolar disorder in adults and children ages 10-to-17, and to reduce irritability in children (5-to-16 years of age) with autistic disorder. There are also some indications that Risperdal is being increasingly used to treat ADHD. While the drug was launched on the market in 1996, the use of Risperdal in children was not approved until 2006.
Among other things, Risperdal gynecomastia plaintiffs allege that Johnson & Johnson failed to provide adequate warnings regarding Risperdal breast growth to patients and doctors. The lawsuits further allege that the company improperly marketed Risperdal for use in children prior to the FDA’s approval of risperdone for pediatric use.
Invega is an atypical antipsychotic drug that contains paliperidone, an active metabolite of risperidone. Risperdone is the active ingredient in Risperdal. The Risperdal lawyers at Bernstein Liebhard LLP are also investigating Invega lawsuit claims on behalf of individuals who suffered gynecomastia that may have been caused by Invega.
Yes. Research on Risperdal male breast development that was published in 2006 in the Journal of Clinical Psychopharmacology found that Risperdal in children may stimulate the production of prolactin. This hormone plays a key role in the development of breasts in girls, and milk production in nursing mothers. According to the study, the use of risperidone for children was linked to the development of gynecomastia in boys and the start of lactation in girls.
In November 2012, Johnson & Johnson agreed to settle charges brought by the U.S. Department of Justice involving the improper marketing of several of its drugs, including Risperdal and Invega. The Invega and Risperdal settlement portion of the agreement resolved charges that the drugs were improperly marketed to children, elderly dementia patients and people with mental disabilities.
Initially it will cost you nothing to retain Bernstein Liebhard LLP for your Risperdal male breast growth lawsuit. You will also not be responsible for any legal fees if your case does not result in a judgment or settlement in your favor. Our attorneys are representing Risperdal lawsuit plaintiffs on a contingency basis, which means our clients only pay legal fees if we obtain a financial recovery in their lawsuit. The legal fees are then taken from a portion of that recovery. Our contingency fee arrangement is fully detailed in the retainer agreement you’ll sign should you retain our Firm, and can be more fully explained by a member of our legal staff.
That depends on the state where you live. Risperdal gynecomastia lawsuits, likely any civil claim, are subject to statutes of limitations that vary from state to state. A statute of limitations sets a firm deadline for when a lawsuit must be filed, and failing to file within this timeframe can eliminate any chance your have for recovery. For that reason, it’s extremely important that you contact a Risperdal lawyer at our Firm today to ensure your legal rights are not placed in jeopardy.
Yes. The Risperdal lawyers at Bernstein Liebhard LLP see their clients as full partners in this litigation of their claims. You will need to keep your attorney updated on your medical condition and treatments, and you should keep track of all of your medical expenses and lost wages associated with your injury. You may also be required to testify at a deposition or trial.
Yes, we are a nationwide law firm and our Risperdal attorneys are available to represent clients in all 50 states.
If you’re ready to pursue a Risperdal gynecomastia lawsuit, please contact Bernstein Liebhard LLP today. For more than 20 years, our legal team has successfully represented hundreds of people harmed by prescription medications and other consumer products, recovering more than $3 billion for our clients. Our Risperdal lawyers will evaluate your case for free, and fully explain the process for filing a Risperdal lawsuit. Simply call our office at .